Abstract. MIRANDA GARCIA, Mª C.. Extended spectrum beta-lactamase – positive Escherichia coli: resistance. Sanid. Mil. [online]. , vol, n.4, pp Tratamiento de las infecciones por microorganismos productores de betalactamasas de espectro extendido: un nuevo reto terapéutico. Prevalencia de betalactamasas de espectro extendido en Escherichia coli, Klebsiella pneumoniae y Klebsiella oxytoca del Hospital Occidente de Kennedy.

Author: Kajinos Fer
Country: Serbia
Language: English (Spanish)
Genre: Sex
Published (Last): 16 December 2018
Pages: 255
PDF File Size: 11.60 Mb
ePub File Size: 4.69 Mb
ISBN: 945-6-42549-767-2
Downloads: 89945
Price: Free* [*Free Regsitration Required]
Uploader: Narg

Most of these isolates had 8 out of the 9 analysed virulence factors. Waging war against uropathogenic Escherichia coli: Services on Demand Article.

San Lorenzo, Parguay editorial iics. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M Un total de 2. Escherichia coli sequence type ST as the major cause of serious multidrug-resistant E.

There was a problem providing the content you requested

En el presente estudio, E. Especttro resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E. The objective was to determine the frequency of ESBL producing Enterobacteriaceae in outpatient and hospitalized patients at the San Roque laboratory from September to November Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina.


The worldwide emergence of clone ST O A case-control study was conducted between August and December of in three Colombian tertiary-care institutions. Manuscrit de l’auteur; accessible dans PMC nov. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.

Escherichia coli portador de betalactamasas de espectro extendido: resistencia

Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: National Center for Biotechnology InformationU. Ann Clin Lab Sci. We conducted a cross-sectional descriptive observational study. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.

Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia. ESBL production was confirmed by both methods in 47 Enterobacteriaceae9.

All participating patients were asked for a urine sample. Diagn Microbiol Infect Dis.

Infect Control Hosp Epidemiol. Resistance in gram-negative bacteria: Extended-spectrum [beta]-lactamase producing Escherichia coli: Otro de los aspectos preocupantes del clon ST de E. While the number of ESBL found is not high, we should insist on taking steps towards reducing the frequency, considering the serious implications of the presence of this enzyme.


Resultados De los 2. Cecilio Baez Campus Universitario – U. Escherichia coli was predominant, followed by Klebsiella pneumoniae.

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Las ITU causadas por E. Clinical and epidemiological information was recorded, and a statistical analysis was performed. Open in a separate window.

Please review our privacy policy.

This article was written by admin